Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL6 Antikörper (AA 256-389)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch BCL6 in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6940527

Kurzübersicht für BCL6 Antikörper (AA 256-389) (ABIN6940527)

Target

Alle BCL6 Antikörper anzeigen
BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

Reaktivität

  • 200
  • 61
  • 25
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 103
  • 95
  • 2
  • 1
Maus

Klonalität

  • 139
  • 62
Monoklonal

Konjugat

  • 88
  • 17
  • 11
  • 10
  • 10
  • 10
  • 10
  • 10
  • 10
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Dieser BCL6 Antikörper ist unkonjugiert

Applikation

  • 100
  • 70
  • 63
  • 40
  • 39
  • 33
  • 18
  • 13
  • 11
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Klon

BCL6-1475
  • Bindungsspezifität

    • 100
    • 11
    • 11
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 256-389

    Spezifität

    The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. Recognizes a protein of 95 kDa, which is identified as Bcl-6. Antibody to bcl-6 is helpful in a number of diagnostic settings: (1) In the differential diagnosis of small B-cell lymphoma. Follicular lymphoma will show bcl-6 (and CD10) positivity whereas other small B-cell lymphomas are usually negative. (2) Bcl-6 is an important prognostic marker in diffuse large B-cell lymphomas (DLBCL), where CD10, bcl-6 and MUM1/IRF4 are used to identify germinal center and activated B-cell phenotypes. (3) Bcl-6 can be valuable in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The Reed-Sternberg cells of classical Hodgkin lymphoma are bcl-6 negative whereas the large ('LH') cells of NLPHL are bcl-6 positive. In contrast, anti-Bcl-6 rarely stains mantle-cell lymphoma and MALT lymphoma.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant human bcl-6 protein fragment (around aa256-389) (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Positive Control: Raji or Ramos cells. Tonsil.

    Known Application: Western Blot (0.5-1 μg/mL)Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

    Andere Bezeichnung

    BCL6

    Molekulargewicht

    95kDa

    Gen-ID

    604

    UniProt

    P41182

    Pathways

    Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Sie sind hier:
Chat with us!